Sei Investments Co. lifted its stake in shares of Taro Pharmaceutical Industries Ltd. (NYSE:TARO) by 21.7% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 10,186 shares of the company’s stock after buying an additional 1,814 shares during the quarter. Sei Investments Co.’s holdings in Taro Pharmaceutical Industries were worth $1,147,000 at the end of the most recent reporting period.

Other large investors also recently modified their holdings of the company. FMR LLC increased its holdings in shares of Taro Pharmaceutical Industries by 42.2% in the 2nd quarter. FMR LLC now owns 466,590 shares of the company’s stock valued at $52,286,000 after acquiring an additional 138,353 shares during the period. APG Asset Management N.V. increased its holdings in shares of Taro Pharmaceutical Industries by 0.4% in the 3rd quarter. APG Asset Management N.V. now owns 223,500 shares of the company’s stock valued at $25,186,000 after acquiring an additional 800 shares during the period. Fort L.P. increased its holdings in shares of Taro Pharmaceutical Industries by 2.1% in the 2nd quarter. Fort L.P. now owns 179,005 shares of the company’s stock valued at $20,059,000 after acquiring an additional 3,748 shares during the period. Dimensional Fund Advisors LP increased its holdings in shares of Taro Pharmaceutical Industries by 35.3% in the 2nd quarter. Dimensional Fund Advisors LP now owns 178,392 shares of the company’s stock valued at $19,991,000 after acquiring an additional 46,570 shares during the period. Finally, Freestone Capital Holdings LLC increased its holdings in shares of Taro Pharmaceutical Industries by 0.3% in the 2nd quarter. Freestone Capital Holdings LLC now owns 142,750 shares of the company’s stock valued at $15,996,000 after acquiring an additional 441 shares during the period. Institutional investors and hedge funds own 13.30% of the company’s stock.

Separately, BidaskClub raised shares of Taro Pharmaceutical Industries from a “sell” rating to a “hold” rating in a research note on Saturday, September 9th.

Shares of Taro Pharmaceutical Industries Ltd. (NYSE TARO) traded down $1.10 on Friday, reaching $104.50. 189,300 shares of the company’s stock traded hands, compared to its average volume of 107,368. The firm has a market cap of $4,234.77, a PE ratio of 13.01 and a beta of 0.62. Taro Pharmaceutical Industries Ltd. has a 12 month low of $94.00 and a 12 month high of $128.46.

COPYRIGHT VIOLATION WARNING: “Taro Pharmaceutical Industries Ltd. (TARO) Stake Increased by Sei Investments Co.” was published by Watch List News and is the sole property of of Watch List News. If you are viewing this story on another domain, it was copied illegally and republished in violation of United States and international copyright laws. The legal version of this story can be viewed at https://www.watchlistnews.com/taro-pharmaceutical-industries-ltd-taro-stake-increased-by-sei-investments-co/1752129.html.

Taro Pharmaceutical Industries Company Profile

Taro Pharmaceutical Industries Ltd. (Taro) is a science-based pharmaceutical company. The Company operates principally through three entities: Taro Pharmaceutical Industries Ltd. (Taro Israel), and two of its subsidiaries, Taro Pharmaceuticals Inc (Taro Canada) and Taro U.SA The Company markets over 200 pharmaceutical products in over 25 countries.

Want to see what other hedge funds are holding TARO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Taro Pharmaceutical Industries Ltd. (NYSE:TARO).

Institutional Ownership by Quarter for Taro Pharmaceutical Industries (NYSE:TARO)

Receive News & Ratings for Taro Pharmaceutical Industries Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Taro Pharmaceutical Industries Ltd. and related companies with Analyst Ratings Network's FREE daily email newsletter.